Upgrade to SI Premium - Free Trial

Benchmark Reiterates Hold Rating on RXO, Inc. (RXO) Following Jury Verdict in Lipe v. Lupus Superior

July 28, 2026 10:22 AM
Benchmark analyst Christopher Kuhn reiterated a Hold rating on RXO, Inc. (NYSE: RXO).The analyst commented, "RXO's valuation has become more ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments